Min Husheng is the founder of GenScript ProBio. GenScript ProBio has raised $240M in total funding. Latest round: Series C. Based in Nanjing, China.
Husheng Min is the CEO of GenScript ProBio, a CDMO platform integrating discovery, pre-clinical, and clinical development services for biologics and gene therapies. Before joining GenScript ProBio, he served as Chief Scientist at Amgen and was instrumental in establishing Samsung Bio.
Full founder directory · Investor directory · Company funding database · Fundraising library